• 検索結果がありません。

Ⅲ 研究成果の刊行物に関する一覧表

N/A
N/A
Protected

Academic year: 2022

シェア "Ⅲ 研究成果の刊行物に関する一覧表"

Copied!
7
0
0

読み込み中.... (全文を見る)

全文

(1)

Ⅲ  研究成果の刊行物に関する一覧表 

(2)

別紙4

研究成果の刊行に関する一覧表

  雑誌

発表者氏名 論文タイトル名 発表誌名 巻号 ページ 出版年 Okuyama A,

Nakamura F, Higashi T.

Prescription trends of prophylactic antiemetics for chemotherapy-induced nausea and vomiting in Japan.

Supportive Cancer Care

(in press) 2014

Ishiguro M, Higashi T,

Watanabe T et al

Changes in colorectal cancer care in Japan before and after guideline publication: a nationwide survey about D3 lymph node dissection and adjuvant chemotherapy.

Journal of the American College of Surgeons

(in press) 2014

Higashi T, Nakamura F, Shibata A  et al

A Nationwide Infrastructure to Support Evidence-based Cancer Care and Cancer Control Policy in Japan

Jpn J Clin Oncol.

(in press) 2013

Nakamura F, Higashi T

Pattern of prophylaxis administration for chemotherapy-induced nausea and vomiting: an analysis of city-based health insurance data.

Int J Clin Oncol.

18(6) 971-6 2013

Higashi T, Nakamura F, Shimada  et al

Quality of Gastric Cancer Care in Designated Cancer Care Hospitals in Japan.

Int J Qual Health Care

25(4) 418-28 2013

Higashi T, Nakamura F, Saruki N, Sobue T.

Establishing a Quality Measurement System for Cancer Care in Japan.

Jpn J Clin Oncol.

43(3) 225-32 2013

(3)

Mekata E, Sonoda H, Shimizu T, Tatsuta T, Yamaguchi T, Endo Y, Tani T. 

Clinical predictive value of in vitro anticancer drug

sensitivity test for the

therapeutic effect of adjuvant  chemotherapy in patients with stage II-III colorectal cancer.

Mol Clin Oncol

1(4) 763-767 2013

Shimizu T, Sonoda H, Murata S, Takebayashi K, Ohta H, Miyake T, Mekata E, Shiomi H, Naka S, Tani T

Hyperthermic intraperitoneal chemotherapy using a

combination of mitomycin C,5-fluorouracil, and

oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study

Eur J Surg Oncol

7983(13) 00943-8 2013

Maehira H,

Shimizu T, Sonoda H, Mekata E, Yamaguchi T, Miyake T, Ishida M, Tani T

A rare case of primary choriocarcinoma in the sigmoid colon.

World J Gastroenterol .

19(39) 6683-8 2013

Mekata E, Murata S, Sonoda H, Shimizu T, Umeda T, Shiomi H, Naka S, Yamamoto H, Abe H, Edamatsu T, Fujieda A, Fujioka M, Wada T, Tani T:

Protein-bound

polysaccharide-K augments the anticancer effect of fluoropyrimidine derivatives possibly by lowering

dihydropyrimidine

dehydrogenase expression in gastrointestinal cancers

Oncol Rep. 10.3892 2788 2013

Takebayashi K, Mekata E, Sonoda H,

Shimizu T, Shiomi H, Naka S, Endo Y, Tani T

Differences in

Chemosensitivity between Primary and Metastatic Tumors in Colorectal Cancer

PLoS One 8(8) 1371 2013

(4)

Mekata E, Endo Y, Sonoda H,

Shimizu T, Kawai Y, Umeda T, Shiomi H, Naka S, Kubota Y, Murata S, Yamamoto H, Abe H, Tani T

Cetuximab as salvage monotherapy in

chemotherapy-refractory metastatic colorectal cancer:

A

single-center report

Publishe d online

2013.

Higashi T, Nakamura F, Shimada Y, Shinkai T, Muranaka T, Kamiike W, Mekata E, Kondo K, Wada Y, Sakai H, Ohtani M, Yamaguchi T, Sugiura N,

Higashide S, Haga Y, Kinoshita A, Yamamoto T, Ezaki T, Hanada S, Makita F, Sobue T, Okamura T

Quality of gastric cancer care in designated cancer care hospitals in Japan

Int J Qual Health Care.

25(4) 418-28 2013

Nagasawa Y, Shimizu T, Sonoda H, Chou

H, Mekata E, Tani T

Is catheter rupture rare after totally implantable access port implantation via the right internal jugular vein?

Report of a case.

Surg Today Jun 4 2013

Takebayashi K, Mekata E, Sonoda H, Shimizu T, Endo Y, Tani T

Clinical potential of the anticancer drug sensitivity test for patients with synchronous stage IV colorectal cancer. Cancer

Cancer Chemother Pharmacol

72(1) 217-22 2013

Sonoda H, Mekata E, Shimizu T,

Safety and efficacy of panitumumab therapy after

Oncol Lett. 5(4) 1331-13 34

2013

(5)

Mekata E, Umeda T, Abe H, Kawai Y, Mori T, Kubota Y, Shiomi H, Naka S, Shimizu T,

Murata S, Yamamoto H,

Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.

Vo TN

Breast Cancer Apr 11 2013

Khanh do T, Mekata E, Mukaisho K, Sugihara H, Shimizu T, Shiomi H, Murata S, Naka S, Yamamoto H, Endo Y, Tani T

Transmembrane mucin MUC1 overexpression and its

association with CD10 myeloid cells, transforming growth factor-β1 expression, and tumor budding grade in colorectal cancer.

Cancer Sci. 104(7) 958-64. 2013

Okumura K, Tani S, Shiogai Y, Kodama

M, Mekata E, Tani T:

[A case of advanced rectal cancer with bladder carcinoma salvaged from myocardial infarction during operation, showing tumor regression by XELOX

treatment, good quality of life

Gan To Kagaku Ryoho

40(1) 111-3 2013

田中 宏和, 片野田 耕太, 東尚弘, 中村 文明, 小林廉毅.

がん診療連携拠点病院における 緩和ケア提供体制と実績評価.

厚生の指標 (印刷中) 2014

Okuyama A, Nakamura F, Higashi T.

Prescription trends of prophylactic antiemetics for chemotherapy-induced nausea and vomiting in Japan.

Support Care Cancer

In press 2014

(6)

Higashi T, Nakamura F, Shimada Y, Shinkai T, Muranaka T, Kamiike W, Mekata E, Kondo K, Wada Y, Sakai H, Ohtani M, Yamaguchi T, Sugiura N,

Higashide S, Haga Y, Kinoshita A, Yamamoto T, Ezaki T, Hanada S, Makita F, Sobue T, Okamura T.

Quality of gastric cancer care in designated cancer care hospitals in Japan.

Int J Qual Health Care

25(4) 2013

Iihara K, Nishimura K, Kada A,

Nakagawara J, Toyoda K, Ogasawara K, Ono J, Shiokawa Y, Aruga T,

Miyachi S, Nagata I, Matsuda S, Ishikawa KB, Suzuki A, Mori H, Nakamura F

J-ASPECT Study

Collaborators. The Impact of Comprehensive Stroke Care Capacity on the Hospital Volume of Stroke

Interventions: A Nationwide Study in Japan

J-ASPECT Study. J Stroke Cerebrovasc Dis.

Oct.5 2013

Nakamura F, Hayashino Y, Nishiuchi T, Kakudate N, Takegami M, Yamamoto Y, Yamazaki S,

Contribution of out-of-hospital factors to a reduction in cardiac arrest mortality after witnessed ventricular

fibrillation or tachycardia.

Resuscitation 84(6) 747-51 2013

(7)

Higashi T, Nakamura F, Saruki N, Takegami M, Hosokawa T, Fukuhara S, Nakayama T, Sobue T

Evaluation of newspaper articles for coverage of public reporting data: a case study of unadjusted cancer survival data

Jpn J Clin Oncol.

43(1) 95-100 2013

Hayashino Y, Jackson JL, Hirata T, Fukumori N, Nakamura F, Fukuhara S, Tsujii S, Ishii H.

Effects of exercise on C-reactive protein,

inflammatory cytokine and adipokine in patients with type 2 diabetes: A

meta-analysis of randomized controlled trials.

Metabolism Epub Nov 23

2013

Higashi T, Nakamura F, Shibata A, Emori Y, Nishimoto H.

The National Database of Hospital-based Cancer Registries: A Nationwide Infrastructure to Support Evidence-based Cancer Care and Cancer Control Policy in Japan.

Jpn J Clin Oncol.

Feb 28 2013

Higashi T, Nakamura F, Saruki N, Sobue T

Establishing a Quality Measurement System for Cancer Care in Japan.

Jpn J Clin Oncol

43(3) 225-32 2013

松本正孝, 濱川正 光, 桜井稔泰, 多田 公英, 池田顕彦, 加 藤達雄, 吉山  崇, 藤山理世, 中村文 明

エタンブトール視神経症の発 生割合と定期的視力検査の有用 性

日呼吸誌 2(3) 87-192 2013

参照

関連したドキュメント

Abbreviations: AR, androgen receptor; BDNF, brain-derived neurotropic factor; DM, diabetes mellitus; DR4, 5, death receptor 4, 5; EGF, epidermal growth factor; GSK3β, glycogen

Contrast-enhanced ultrasonography, oral cancer, oropharyngeal cancer, sentinel lymph node, Sonazoid TM , Superb Microvascular

In this study, we investigated whether tranilast inhibits the effects of TGF-b-induced EMT in HPMCs by inhibiting the TGF-b/Smad pathway, and whether fibrosis can be attenuated in

reported that gemcitabine-mediated apoptosis is caspase- dependent in pancreatic cancers; Jones et al [14] showed that gemcitabine-induced apoptosis is achieved through the

To determine the promoter activities of 5 ′ -flanking region of the human Pim-3 gene, we subcloned various deleted 5 ′ -flanking regions of the human Pim-3 gene into a

Late relapse of testicular cancer 21 years after first complete remission: a

In 2003, Agiza and Elsadany 7 studied the duopoly game model based on heterogeneous expectations, that is, one player applied naive expectation rule and the other used

In order to relieve influence of unfair arguments, a Gaussian distribution-based argument-dependent weighting method and a hybrid support-function-based argument-dependent